ANZEN

This brand name is authorized in Hong Kong

Active ingredients

The drug ANZEN contains one active pharmaceutical ingredient (API):

1 Serrapeptase UNII NL053ABE4J - SERRAPEPTASE
Serrapeptase suppresses fibrinolytic activity and increased vascular permeability, suppresses edema of inflammation, strongly hydrolyzes bradykinin and cleaves fibrin and fibrinogen without affecting proteins. Read about Serrapeptase

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B06AA	Enzymes	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents
Discover more medicines within B06AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 57445

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.